Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.

Publication Year: 2011

DOI:
10.1038/ajg.2011.443

PMCID:
PMC3321505

PMID:
22186979

Journal Information

Full Title: Am J Gastroenterol

Abbreviation: Am J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Guarantor of the article: Loren Laine, MD.: Specific author contributions: Planning and conducting study, analysis/interpretation of data, drafting and revision of the manuscript, approved the final draft submitted: Loren Laine; planning and conducting study, collecting data, interpretation of data, critical review of the manuscript, approved the final draft submitted: Alan J. Kivitz, Alfonso E. Bello, and Michael H. Schiff; analysis/interpretation of data, critical review of the manuscript, approved the final draft submitted: Amy Y. Grahn; analysis/interpretation of data; drafting and critical review of the manuscript, approved the final draft submitted: Ali S. Taha.: Financial support: This study received funding and drugs from Horizon Pharma. The study was designed in collaboration between the sponsors and authors; the sponsor was responsible for collecting data; statistical analyses were performed by the sponsor under the direction of the sponsor and the authors; interpretation of the data and writing of the manuscript were performed by the authors.: Potential competing interests: Loren Laine is a consultant for Horizon Pharma, AstraZeneca, Eisai, and Logical Therapeutics; is on the Data Safety Monitoring Board for Merck, Bayer, and BMS. Alfonso E. Bello is a consultant for Horizon Pharma and Pfizer; is a speaker for Abbott and Amgen. Amy Y. Grahn is an employee of Horizon Pharma. Michael H. Schiff is a consultant for Horizon Pharma. Ali S. Taha is a consultant for Horizon Pharma and Astellas Pharma."

Evidence found in paper:

"Financial support : This study received funding and drugs from Horizon Pharma. The study was designed in collaboration between the sponsors and authors; the sponsor was responsible for collecting data; statistical analyses were performed by the sponsor under the direction of the sponsor and the authors; interpretation of the data and writing of the manuscript were performed by the authors."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025